Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 18.38 GBp
Change Today +0.88 / 5.00%
Volume 147.9K
As of 4:03 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

eden research plc (EDEN) Snapshot

Open
17.50 GBp
Previous Close
17.50 GBp
Day High
18.38 GBp
Day Low
17.50 GBp
52 Week High
06/3/15 - 25.88 GBp
52 Week Low
11/12/14 - 6.88 GBp
Market Cap
29.2M
Average Volume 10 Days
641.7K
EPS TTM
--
Shares Outstanding
158.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for EDEN RESEARCH PLC (EDEN)

Related News

No related news articles were found.

eden research plc (EDEN) Related Businessweek News

No Related Businessweek News Found

eden research plc (EDEN) Details

Eden Research Plc develops and markets intellectual property, primarily in the areas of encapsulation, terpenes, and environmentally friendly technologies in the United Kingdom. The company provides products in the areas of foliar disease control, soil pests, protected glass house crops, post harvest applications, and vascular disease control. It offers 3AEY, a terpene based fungicide; and develops various products for the control of botrytis, powdery mildew, nematodes, whitefly, and spider mites. The company was formerly known as Ximed Group plc and changed its name to Eden Research Plc as a result of its merger with Eden Research Inc in 2003. Eden Research Plc was incorporated in 1995 and is headquartered in Cirencester, the United Kingdom.

6 Employees
Last Reported Date: 03/30/15
Founded in 1995

eden research plc (EDEN) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: 36.0K GBP
Chief Financial Officer, Director and Member ...
Total Annual Compensation: 87.5K GBP
Compensation as of Fiscal Year 2014.

eden research plc (EDEN) Key Developments

Eden Research PLC, Annual General Meeting, Jun 10, 2015

Eden Research PLC, Annual General Meeting, Jun 10, 2015., at 12:00 GMT Standard Time. Location: The Four Pillars Hotel. Agenda: To receive, consider and adopt the company's annual accounts and financial statements for the year ended 31 December 2014 together with the directors' report and auditors' report on those accounts; to re-appoint UHY Hacker Young as auditors to the Company until the conclusion of the next annual general meeting of the company and to authorize the directors to determine their remuneration; to elect as a director, Sean Michael Smith, who being eligible is offering himself for election; to elect as a director, Sean Michael Smith, who being eligible is offering himself for election; to consider the directors be and are generally and unconditionally authorized to exercise all powers of the company to allot relevant securities; and to consider special resolution.

Eden Research PLC Appoints Robin Cridland as Non-Executive Director Effective from 8 May 2015

Revolymer plc announced that its CFO and Company Secretary Robin Cridland has been appointed as a non-executive director of Eden Research Plc, effective from 8 May 2015. The board of Revolymer views such an appointment as positive for both Revolymer and the professional development of its management, and accordingly congratulates Rob on his appointment.

Eden Research plc Announces the Option Agreement with Taminco BVBA

Eden Research Plc announced that it has signed an exclusive option agreement with Taminco BVBA' s crop protection division following a series of field trials conducted during the second half of 2014. The agreement grants Taminco the right to further evaluate and conduct large-scale marketing and regulatory trials with Eden's nematicide product B2Y for crop protection until March 31, 2016. It is anticipated that following a outcome in 2015, Eden and Taminco will negotiate a global licensing arrangement to allow the commercialization of this product.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EDEN:LN 18.38 GBp +0.88

EDEN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EDEN.
View Industry Companies
 

Industry Analysis

EDEN

Industry Average

Valuation EDEN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 223.9x
Price/Book 4.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 277.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EDEN RESEARCH PLC, please visit www.edenresearch.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.